If you sell nutraceuticals online and keep getting rejected by Stripe, PayPal or Square, you’re not alone—mainstream processors flag this vertical daily and close accounts the moment chargebacks tick up.
This guide explains exactly what a nutraceutical merchant account is, why mainstream providers reject the category, and how to line up a replacement processor that can handle the compliance load without shutting you down.
A nutraceutical merchant account is a specialized payment-processing relationship designed for businesses that sell dietary supplements, vitamins, herbal products, functional foods, or other non-drug products marketed for health benefits.
Unlike standard merchant accounts, these accounts are underwritten for elevated risk because regulators, card networks and banks treat health-related claims as a compliance minefield where even subtle wording can trigger investigations and account freezes.
High-risk processors price for this risk with an effective discount rate of roughly 3.95 %–4.95 % plus a small per-transaction fee and often apply a rolling reserve of 5 %–10 % held for up to six months to cover potential chargebacks.
Mainstream processors reject nutraceuticals primarily because the category sits in a regulatory gray zone: the FTC and FDA scrutinize advertising claims, and card networks monitor disputes aggressively under programs like Visa’s Acquirer Monitoring Program (VAMP).
Free-trial or continuity billing models generate high first-chargeback rates when customers claim they never agreed to recurring billing, causing processors to classify nutraceuticals as “continuity” or “negative-option” offers with elevated risk.
LegitScript’s 2023 supplement-category report shows a dispute-to-transaction ratio of 0.9 % is the danger threshold; once your ratio crosses that line, acquirers will either jack up reserves or terminate the account within weeks.
Any e-commerce store or subscription service that sells vitamins, minerals, probiotics, nootropics, herbal extracts or other ingestible products marketed for health maintenance or enhancement needs a dedicated nutraceutical merchant account.
Businesses running affiliate funnels, influencer campaigns or social-media ads that make implied health claims are also classified as high-risk because the ad copy can be cited as deceptive under the FTC’s .com Disclosures guidance.
Underwriters require documented evidence that your business model complies with FTC and FDA guidance on substantiation and disclosures, including a claims-substantiation file that shows clinical or scientific support for every health statement you make.
You must provide clear, conspicuous disclosures on landing pages, checkout pages and order confirmations that explain auto-ship terms, refund windows and the process to cancel recurring billing, using language regulators have already blessed in NAD or FTC decisions.
Processor-specific requirements include at least six months of processing history from another high-risk provider, or, if you’re brand-new, a detailed business plan with supplier invoices, product formulations and marketing-copy samples that pass LegitScript’s vetting checklist.
Financials matter: underwriters expect at least three months of clean merchant statements and a personal FICO score above 650; startups without processing history may need to place an additional rolling reserve of 10 %–15 % for the first year.
Expect an effective discount rate of roughly 3.95 %–4.95 % plus a per-transaction fee of $0.20–$0.35 when you qualify for a nutraceutical merchant account with a high-risk processor.
Most providers impose a rolling reserve of 5 %–10 % that releases in stages over three to six months as your dispute ratio remains below the 0.9 % VAMP threshold.
To reduce reserve requirements and improve approval odds, operators often load-balance across two or three separate merchant IDs (MIDs) so that no single MID accumulates too many disputes; this also lowers the impact if one MID triggers a monitoring alert.
Some processors allow you to segment continuity offers into a dedicated MID with a higher reserve, keeping your core product MID cleaner and easier to renew at lower cost.
| Rolling Reserve Tiers | Reserve % |
|---|---|
| 0–0.4 % dispute ratio | 5 % |
| 0.4 %–0.7 % dispute ratio | 7 % |
| 0.7 %–0.9 % dispute ratio | 10 % |
| >0.9 % dispute ratio | 15 % or termination |
The single biggest reason applications are declined is unsubstantiated or implied health claims in marketing copy; underwriters run automated scans against LegitScript’s database and cross-check with FTC precedent to flag anything that looks like an unapproved health claim.
Free-trial or continuity programs without clear upfront disclosure of billing terms and cancellation policies trigger immediate declines because they map directly to card-network chargeback codes 13.1 (recurring) and 13.3 (free-to-paid).
Lack of prior processing history in the nutraceutical space forces underwriters to treat you as a brand-new risk, which often results in a 12–18-month rolling hold or outright rejection; the fix is to onboard with an aggregator or a processor willing to seed-fund a new MID with higher reserves.
Regulatory red flags—such as prior warning letters from the FTC, NAD decisions against your ads, or LegitScript warnings—can halt approvals for months; the fastest path is to clean up claims language and provide a remediation plan before you reapply.
Monitor your dispute ratio every week; if it drifts above 0.7 %, throttle new ad spend and send win-back offers to reduce refunds before you breach the 0.9 % VAMP threshold that triggers automatic monitoring.
Use a dispute-management platform that automates evidence packet assembly with signed order confirmations, tracking numbers and product-formulation substantiation so you can respond to chargebacks within the 30-day network deadline.
Segment your traffic by funnel type: run continuity offers on a dedicated MID with a 10 % rolling reserve, while placing one-time sales on a separate MID with a 5 % reserve to isolate risk.
Maintain a clean refund and cancellation log; cardholders who request refunds within the first seven days are far less likely to file chargebacks if your refund policy is clearly posted and honored automatically.
If your existing processor terminates the account, request the full reason in writing and gather remediation evidence—clean ad copy, updated disclosures, and a revised continuity policy—before you apply to a new high-risk provider.
Expect a new application to ask for a signed attestation that you have removed or revised any claims flagged in the termination letter; processors share termination reasons through a shared database, so omitting this step will trigger an automatic decline.
Prepare for a longer boarding process and higher reserves; some processors will seed-fund a new MID with a 15 % rolling reserve for the first six months if prior history shows elevated disputes.
If you operated under an aggregator like Square or Stripe, aggregators can hold funds for up to 180 days while they complete an investigation; factor this cash-flow gap into your runway planning.
See if your business qualifies →Industry data from 2023 shows that roughly 70 % of nutraceutical applications are declined by mainstream processors, primarily due to elevated chargeback risk and regulatory scrutiny of health claims.
Even if vitamins are a small part of your catalog, card networks classify the merchant category by the predominant risk profile of the business; if health-related products drive any material revenue, processors will categorize you as a nutraceutical merchant and apply high-risk underwriting.
Approval timelines vary from 5–10 business days for established brands with clean history to 3–6 weeks for new entrants without prior processing history; the process hinges on document turnaround and underwriter queue time.
There is no single “cheapest” option; focus on effective discount rates, reserve requirements and support quality rather than headline pricing alone, as a low headline rate with a 15 % rolling reserve can cost more than a slightly higher rate with a 5 % reserve.
Processors monitor continuously; if your dispute ratio climbs above 0.9 %, the Visa Acquirer Monitoring Program (VAMP) triggers enhanced oversight that may result in higher reserves or account termination within weeks, so prevention and rapid response are critical.